Libo Pharma Corp. (TPEX: 7888)
Health Care · Biotechnology · TW
NT$29.35
-3.77% today · -37.8% 1Y
Libo Pharma Corp. (TPEX: 7888) operates in the Biotechnology industry within the Health Care sector. The company is valued at $68.06M.
Over the last twelve months the share price has lost 37.8%, trading between 27.50 and 69.00.
Tweenvest scores Libo Pharma Corp. across four factors: quality 49/100, value 58/100. Its strongest factor is value.
7888 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $68.06M
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -4.88
- Dividend yield
- —
- Beta (5Y)
- —
- 52-week high
- NT$69.00
- 52-week low
- NT$27.50
- Avg volume (3M)
- —
- Shares outstanding
- 75.23M
- Employees
- —
- Next earnings
- —
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Cardiff Oncology, Inc.NasdaqCM: CRDF | $70.10M | $0.90 | -16.56% |
| MediciNova, Inc.NasdaqGM: MNOV | $69.89M | $1.42 | -6.58% |
| Gwo Xi Stem Cell Applied Technology Co. , LtdTPEX: 6704 | $68.90M | NT$23.30 | -2.10% |
| Heron Therapeutics, Inc.NasdaqCM: HRTX | $68.54M | $0.36 | -11.11% |
| Artgen Biotech PJSCMISX: ISKJ | $68.01M | RUB— | — |
| MAIA Biotechnology, Inc.NYSEAM: MAIA | $66.91M | $1.10 | -9.84% |
| BIO-FD&C Co.,Ltd.KOSDAQ: A251120 | $66.79M | ₩10,240.00 | +1.19% |
| Curasight A/SNGM: CURAS | $66.59M | Dkr— | — |
Figures last refreshed Oct 18, 2026.